Health & Medicine
New Drug Approved by FDA for Menopausal Women: Duavee
Kathleen Lees
First Posted: Oct 04, 2013 03:59 PM EDT
A new drug has just been approved for menopausal women, according to the U.S. Food and Drug Administration. The drug, approved by Pfizer Inc.'s, is known as Duavee.
It includes a mix of estrogens and bazedoxifene that only need to be taken once a day, according to the organization. The drug should be prescribed to menopausal women who have not had a hysterectomy and can also be taken by post-menopausal women in order to prevent osteoporosis.
As women go through menopause, they experience a wide range of symptoms including a significant change in their bodies that can cause unpleasant problems such as hot flashes and mood swings. This can be very difficult to deal with, and many drugs available can often times provide unwanted side effects.
Yet this new drug was finally approved by the Food and Drug Administration (FDA) and used in phase 3 clinical trials. One of the trials reported that women who took the drug saw a reduction in moderate-to-severe hot flashes by up to 74 percent just after 12 weeks. Yet the women who took the medicine during this trial only saw a 47 percent reduction.
Various reports also show that women who took the medication showed increased levels of bone mineral density when compared to those that took placebos. The increases were seen in both the hip and lumbar spine around one to two years following treatment.
Yet the drug is not without side effects, ranging from muscle spasms, diarrhea, nausea, abdominal pains, dizziness, neck pain and throat pain.
Only your doctor can determine if this drug would be right for you.
The tablet will be available during the first quarter of 2014. The U.S. is the only country to have approved Duavee so far.
See Now:
NASA's Juno Spacecraft's Rendezvous With Jupiter's Mammoth Cyclone
TagsHealth ©2024 ScienceWorldReport.com All rights reserved. Do not reproduce without permission. The window to the world of science news.
More on SCIENCEwr
First Posted: Oct 04, 2013 03:59 PM EDT
A new drug has just been approved for menopausal women, according to the U.S. Food and Drug Administration. The drug, approved by Pfizer Inc.'s, is known as Duavee.
It includes a mix of estrogens and bazedoxifene that only need to be taken once a day, according to the organization. The drug should be prescribed to menopausal women who have not had a hysterectomy and can also be taken by post-menopausal women in order to prevent osteoporosis.
As women go through menopause, they experience a wide range of symptoms including a significant change in their bodies that can cause unpleasant problems such as hot flashes and mood swings. This can be very difficult to deal with, and many drugs available can often times provide unwanted side effects.
Yet this new drug was finally approved by the Food and Drug Administration (FDA) and used in phase 3 clinical trials. One of the trials reported that women who took the drug saw a reduction in moderate-to-severe hot flashes by up to 74 percent just after 12 weeks. Yet the women who took the medicine during this trial only saw a 47 percent reduction.
Various reports also show that women who took the medication showed increased levels of bone mineral density when compared to those that took placebos. The increases were seen in both the hip and lumbar spine around one to two years following treatment.
Yet the drug is not without side effects, ranging from muscle spasms, diarrhea, nausea, abdominal pains, dizziness, neck pain and throat pain.
Only your doctor can determine if this drug would be right for you.
The tablet will be available during the first quarter of 2014. The U.S. is the only country to have approved Duavee so far.
See Now: NASA's Juno Spacecraft's Rendezvous With Jupiter's Mammoth Cyclone